Nakayama Masashi, Bennett Christina J, Hicks Jessica L, Epstein Jonathan I, Platz Elizabeth A, Nelson William G, De Marzo Angelo M
Department of Pathology, the Johns Hopkins Medical Institutions, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Baltimore, MD 21231, USA.
Am J Pathol. 2003 Sep;163(3):923-33. doi: 10.1016/s0002-9440(10)63452-9.
Somatic inactivation of the glutathione S-transferase-pi gene (GSTP1) via CpG island hypermethylation occurs early during prostate carcinogenesis, present in approximately 70% of high-grade prostatic intraepithelial neoplasia (high-grade PIN) lesions and more than 90% of adenocarcinomas. Recently, there has been a resurgence of the concept that foci of prostatic atrophy (referred to as proliferative inflammatory atrophy or PIA) may be precursor lesions for the development of prostate cancer and/or high-grade PIN. Many of the cells within PIA lesions contain elevated levels of GSTP1, glutathione S-transferase-alpha (GSTA1), and cyclooxygenase-II proteins, suggesting a stress response. Because not all PIA cells are positive for GSTP1 protein, we hypothesized that some of the cells within these regions acquire GSTP1 CpG island hypermethylation, increasing the chance of progression to high-grade PIN and/or adenocarcinoma. Separate regions (n =199) from 27 formalin-fixed paraffin-embedded prostates were microdissected by laser-capture microdissection (Arcturus PixCell II). These regions included normal epithelium (n = 48), hyperplasticepithelium from benign prostatic hyperplasia nodules (n = 22), PIA (n = 64), high-grade PIN (n = 32), and adenocarcinoma (n = 33). Genomic DNA was isolated and assessed for GSTP1 CpG island hypermethylation by methylation-specific polymerase chain reaction. GSTP1 CpG island hypermethylation was not detected in normal epithelium (0 of 48) or in hyperplastic epithelium (0 of 22), but was found in 4 of 64 (6.3%) PIA lesions. The difference in the frequency of GSTP1 CpG island hypermethylation between normal or hyperplastic epithelium and PIA was statistically significant (P = 0.049). Similar to studies using nonmicrodissected cases, hypermethylation was found in 22 of 32 (68.8%) high-grade PIN lesions and in 30 of 33 (90.9%) adenocarcinoma lesions. Unlike normal or hyperplastic epithelium, GSTP1 CpG island hypermethylation can be detected in some PIA lesions. These data support the hypothesis that atrophic epithelium in a subset of PIA lesions may lead to high-grade PIN and/or adenocarcinoma. Because these atrophic lesions are so prevalent and extensive, even though only a small subset contains this somatic DNA alteration, the clinical impact may be substantial.
通过CpG岛高甲基化导致的谷胱甘肽S-转移酶-π基因(GSTP1)的体细胞失活在前列腺癌发生的早期就会出现,大约70%的高级别前列腺上皮内瘤变(高级别PIN)病变以及超过90%的腺癌中都存在这种情况。最近,前列腺萎缩灶(称为增殖性炎性萎缩或PIA)可能是前列腺癌和/或高级别PIN发生的前驱病变这一概念再度兴起。PIA病变中的许多细胞含有升高水平的GSTP1、谷胱甘肽S-转移酶-α(GSTA1)和环氧合酶-II蛋白,提示一种应激反应。由于并非所有PIA细胞的GSTP1蛋白都呈阳性,我们推测这些区域内的一些细胞发生了GSTP1 CpG岛高甲基化,增加了进展为高级别PIN和/或腺癌的可能性。通过激光捕获显微切割(Arcturus PixCell II)从27个福尔马林固定石蜡包埋的前列腺中显微切割出单独的区域(n = 199)。这些区域包括正常上皮(n = 48)、良性前列腺增生结节的增生上皮(n = 22)、PIA(n = 64)、高级别PIN(n = 32)和腺癌(n = 33)。分离基因组DNA,并通过甲基化特异性聚合酶链反应评估GSTP1 CpG岛高甲基化情况。在正常上皮(48个样本中0个)或增生上皮(22个样本中0个)中未检测到GSTP1 CpG岛高甲基化,但在64个PIA病变中的4个(6.3%)中发现了该现象。正常或增生上皮与PIA中GSTP1 CpG岛高甲基化频率的差异具有统计学意义(P = 0.049)。与使用未显微切割病例的研究相似,在32个高级别PIN病变中的22个(68.8%)以及33个腺癌病变中的30个(90.9%)中发现了高甲基化。与正常或增生上皮不同,在一些PIA病变中可检测到GSTP1 CpG岛高甲基化。这些数据支持了以下假设,即PIA病变子集内的萎缩上皮可能导致高级别PIN和/或腺癌。由于这些萎缩性病变非常普遍且广泛,即使只有一小部分包含这种体细胞DNA改变,其临床影响可能也很大。